Diseases & Disorders
(G30)
IRS Verified
DX Registered
ABIGAIL ALLIANCE FOR BETTER ACCESS TO DEVELOPMENTAL DRUGS INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$227
Total Revenue
$475
Total Expenses
N/A
Net Assets
1
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $227 | $475 | N/A | — | 1 |
| 2022 | $57 | $47 | N/A | — | 1 |
| 2021 | $3K | $22K | N/A | — | 1 |
| 2020 | $2K | $13K | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.